Carboplatin, Cyclophosphamide, Doxorubicin, Paclitaxel, and Pembrolizumab
About
Membership operator: AND
Therapies: 5
Therapies
Carboplatin (tx:ncit:C1282)
Cyclophosphamide (tx:ncit:C405)
Doxorubicin (tx:ncit:C456)
Paclitaxel (tx:ncit:C1411)
Pembrolizumab (tx:ncit:C106432)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | ER negative, HER2-negative, PR negative | Invasive Breast Carcinoma | Carboplatin, Cyclophosphamide, Doxorubicin, Paclitaxel, Pembrolizumab |